KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Short-term Investments (2020 - 2025)

Historic Short-term Investments for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $1.2 billion.

  • Oscar Health's Short-term Investments rose 9480.18% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 9480.18%. This contributed to the annual value of $1.2 billion for FY2025, which is 9480.18% up from last year.
  • Oscar Health's Short-term Investments amounted to $1.2 billion in Q4 2025, which was up 9480.18% from $887.6 million recorded in Q3 2025.
  • Over the past 5 years, Oscar Health's Short-term Investments peaked at $1.4 billion during Q4 2022, and registered a low of $363.6 million during Q2 2024.
  • Over the past 5 years, Oscar Health's median Short-term Investments value was $734.9 million (recorded in 2022), while the average stood at $811.4 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first plummeted by 7104.1% in 2024, then soared by 15797.62% in 2025.
  • Quarter analysis of 5 years shows Oscar Health's Short-term Investments stood at $587.1 million in 2021, then skyrocketed by 138.0% to $1.4 billion in 2022, then tumbled by 50.63% to $689.8 million in 2023, then fell by 9.48% to $624.5 million in 2024, then surged by 94.8% to $1.2 billion in 2025.
  • Its Short-term Investments stands at $1.2 billion for Q4 2025, versus $887.6 million for Q3 2025 and $938.1 million for Q2 2025.